REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Diagnofarm S.A. (Ecuador)

Main Activities: All Other Miscellaneous Ambulatory Health Care Services
Full name: Diagnofarm S.A. Profile Updated: April 16, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Spanish Download a sample report

Diagnofarm S.A is a health and medicine company. It specializes in distributing vaccines from manufacturers such as GlaxoSmithKline, Pfizer, Merck Sharp & Dohme, and Sanofi Pasteur. The company provides vaccines to doctors, institutions, and companies in the city of Quito and its valleys, and conducts adult vaccination campaigns at the national level. Diagnofarm has expertise in handling organic products that require special storage conditions to preserve the cold chain.

Headquarters
Pradera, Ecomedica Bldg.
Quito; Pichincha;

Contact Details: Purchase the Diagnofarm S.A. report to view the information.

Website: http://www.diagnofarm.com

Basic Information
Total Employees:
Purchase the Diagnofarm S.A. report to view the information.
Outstanding Shares:
Purchase the Diagnofarm S.A. report to view the information.
Registered Capital:
Purchase the Diagnofarm S.A. report to view the information.
Incorporation Date:
January 18, 2008
Key Executives
Purchase this report to view the information.
President
Purchase this report to view the information.
General Manager
Ownership Details
Purchase this report to view the information.
22%
Purchase this report to view the information.
20%
Purchase this report to view the information.
4%
Purchase this report to view the information.
4%
Purchase this report to view the information.
2%
Company Performance
Financial values in the chart are available after Diagnofarm S.A. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency USD. Absolute financial data is included in the purchased report.
Net sales revenue
22.94%▲
Total operating revenue
23.15%▲
Operating profit (EBIT)
109.86%▲
EBITDA
102.07%▲
Net Profit (Loss) for the Period
151.47%▲
Total assets
19.04%▲
Total equity
26.19%▲
Operating Profit Margin (ROS)
0.8%▲
Net Profit Margin
0.5%▲
Return on Equity (ROE)
10.34%▲
Debt to Equity Ratio
22.29%▲
Quick Ratio
-0%
Cash Ratio
-0.03%▼

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo